Brown University Oncology Research Group (BrUOG)

The Brown University Oncology Research Group (BrUOG) has become a highly respected cancer research group because of its history of innovative clinical trials. These investigations evaluate early, cutting-edge applications of chemotherapy, biologic agents and other cancer treatments in both Phase I (which determine the optimally tolerated dose of an anticancer treatment regimen) and Phase II trials (which assesses the potential therapeutic effectiveness). BrUOG has provided essential preliminary data for definitive Phase III trials, which are being conducted Nationwide.

Our Mission is to

  • improve cancer care through the implementation of innovative, multidisciplinary clinical cancer trials
  • provide novel cancer therapies to BrUOG-affiliated hospitals
  • provide a unifying infrastructure for Brown affiliated hospital to share, advance and produce ideas on treatment of cancer